Dr. Fernandez conducted research at some of the world’s leading institutions, including in Argentina, the United Kingdom, the United States, and Germany.
ViewMind technology shows remarkable accuracy, as evidenced in 25 peer-reviewed publications and supported by clinical data on thousands of patients studied across four continents in scores of clinical trials, including a 4-year longitudinal study and studies in familial populations.
Mario Parra, Juan Granada, Gerardo Fernandez
Alzheimers Dement (Amst), 2022
Traditional neuropsychological assessment tests are primarily concerned with behavioral response. Is the provided answer correct or incorrect? The majority of the cognitive decision-making signal is disregarded.
ViewMind’s technology analyzes every cognitive processing step based on eye-movement responses to visual stimuli. The signal fidelity is over a million times greater than traditional assessments. ViewMind employs Ocular Digital Phenotyping using context-aware artificial intelligence to assess the status of 16 cognitive domains and 19 related brain regions. In the second analysis stage, the phenotypes of neurodegenerative diseases have been derived and validated in collaboration with some of the world’s leading expert clinicians and researchers.
ViewMind measures eye-movement responses to visual stimuli using VR headsets that are more accurate compared to separate camera sensors. They also provide a clinically controlled environment. Eye movement patterns change precisely and repeatedly based on alterations in cognition, like fingerprints, so having the most sensitive instrument for these measurements is key.